TKNO

Alpha Teknova, Inc. [TKNO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TKNO Stock Summary

Top TKNO Correlated Resources

TKNO


Top 10 Correlated ETFs

TKNO


Top 10 Correlated Stocks

TKNO


In the News

08:04 22 Mar 2023 TKNO

Alpha Teknova, Inc. (TKNO) Q4 2022 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q4 2022 Results Conference Call March 15, 2023 5:00 PM ET Company Participants Jen Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matt Lowell - Chief Financial Officer Conference Call Participants Joseph Flanagan - Cowen Matt Larew - William Blair Hannah Hefley - Stephens Operator Thank you for standing by, and welcome to Teknova's Fourth Quarter and Full Year 2022 Financial Results Call. At this time, all participants are in a listen-only mode.

08:02 22 Mar 2023 TKNO

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

08:00 22 Mar 2023 TKNO

Teknova to Participate in Upcoming Investor Conferences

HOLLISTER, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conferences:

04:42 22 Mar 2023 TKNO

Alpha Teknova, Inc. (TKNO) Q3 2022 Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q3 2022 Earnings Conference Call November 21, 2022 4:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Teknova Third Quarter 2022 Financial Results Conference Call.

04:01 22 Mar 2023 TKNO

Teknova to Participate in Upcoming Investor Conferences

HOLLISTER, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, research, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conferences:

04:01 22 Mar 2023 TKNO

Teknova to Report Third Quarter 2022 Financial Results on November 9, 2022

HOLLISTER, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2022, on Wednesday, November 9, 2022, following the close of market.

04:01 22 Mar 2023 TKNO

Teknova to Participate in Upcoming Investor Conference

HOLLISTER, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conference.

07:43 22 Mar 2023 TKNO

Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q2 2022 Results - Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Stephanie Yan - Cowen Matt Larew - William Blair Jake Johnson - Stephens Operator Good day, and thank you for standing by. Welcome to the Teknova Second Quarter 2022 Financial Results Conference Call.

04:01 22 Mar 2023 TKNO

Teknova to Report Second Quarter 2022 Financial Results on August 10, 2022

HOLLISTER, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2022, on Wednesday, August 10, 2022, following the close of market.

07:37 22 Mar 2023 TKNO

Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q1 2022 Results - Earnings Call Transcript

Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Matthew Larew - William Blair Stephanie Yan - Cowen and Company Jacob Johnson - Stephens, Inc. Operator Good day, and thank you for standing by. Welcome to the Teknova First Quarter 2022 Financial Results Conference Call.

TKNO Financial details

Company Rating
Buy
Market Cap
90.3M
Income
-47.47M
Revenue
41.42M
Book val./share
3.99
Cash/share
1.77
Dividend
-
Dividend %
-
Employees
237
Optionable
No
Shortable
Yes
Earnings
09 Nov 2022
P/E
-2.42
Forward P/E
-
PEG
-0.09
P/S
2.1
P/B
0.82
P/C
1.84
P/FCF
-1.72
Quick Ratio
4.56
Current Ratio
5.68
Debt / Equity
0.43
LT Debt / Equity
0.4
-
-
EPS (TTM)
-1.69
EPS next Y
-
EPS next Q
-
EPS this Y
263.97%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-26.2%
EPS Q/Q
-41.25%
-
-
-
-
SMA20
-37.39%
SMA50
-35.34%
SMA100
-1.11%
Inst Own
19.19%
Inst Trans
-3.58%
ROA
-24%
ROE
-29%
ROC
-0.27%
Gross Margin
47%
Oper. Margin
-92%
Profit Margin
-87%
Payout
-
Shs Outstand
28.13M
Shs Float
6.93M
-
-
-
-
Target Price
-
52W Range
3.02-17.6
52W High
-80.82%
52W Low
+8.67%
RSI
19.2
Rel Volume
0.83
Avg Volume
46.21K
Volume
38.22K
Perf Week
-13.76%
Perf Month
-45.48%
Perf Quarter
-9.19%
Perf Half Y
-13.07%
-
-
-
-
Beta
-
-
-
Volatility
0.13%, 0.97%
Prev Close
3.16%
Price
3.26
Change
0.93%

TKNO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2019-12-312020-12-31 2021-12-31
Revenue per share
0.961.481.75
Net income per share
-0.060.17-0.46
Operating cash flow per share
0.10.12-0.43
Free cash flow per share
-0.02-0.14-1.37
Cash per share
0.460.240
Book value per share
2.312.480.01
Tangible book value per share
0.520.760.01
Share holders equity per share
2.312.480.01
Interest debt per share
00-0.03
Market cap
525.89M527.8M432.37M
Enterprise value
521.79M524.48M432.3M
P/E ratio
-402.98147.84-44.11
Price to sales ratio
26.1716.8611.72
POCF ratio
242.12210.7-47.68
PFCF ratio
-1.1K-178.25-14.94
P/B Ratio
10.8310.073.02K
PTB ratio
10.8310.073.02K
EV to sales
25.9716.7611.72
Enterprise value over EBITDA
-2.95K77.47-41.8
EV to operating cash flow
240.24209.37-47.67
EV to free cash flow
-1.09K-177.13-14.93
Earnings yield
00.01-0.02
Free cash flow yield
0-0.01-0.07
Debt to equity
0.210.20.16
Debt to assets
0.170.170.14
Net debt to EBITDA
23.16-0.490.01
Current ratio
2.764.1413.07
Interest coverage
0020.39
Income quality
-1.660.70.93
Dividend Yield
000
Payout ratio
000
Sales general and administrative to revenue
0.380.260.55
Research and developement to revenue
0.040.050.12
Intangibles to total assets
0.640.580.21
Capex to operating cash flow
-1.22-2.182.19
Capex to revenue
-0.13-0.17-0.54
Capex to depreciation
-1.63-2.67-6.89
Stock based compensation to revenue
00.010.04
Graham number
1.793.070.27
ROIC
-0.030.06864.67
Return on tangible assets
-0.060.13-74.72
Graham Net
0.150.060
Working capital
9.84M12.45M93.46K
Tangible asset value
10.94M15.94M107.89K
Net current asset value
5.45M5.91M77.9K
Invested capital
000.08
Average receivables
04.78M3.29M
Average payables
01.2M818.62K
Average inventory
03.07M1.79M
Days sales outstanding
54.2476.610.05
Days payables outstanding
24.3344.070.04
Days of inventory on hand
81.396.550.1
Receivables turnover
6.734.767.91K
Payables turnover
158.288.57K
Inventory turnover
4.493.783.57K
ROE
-0.030.07-68.46
Capex per share
-0.13-0.26-0.94

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
0.340.360.40.420.38
Net income per share
-0.12-0.13-0.2-0.22-0.8
Operating cash flow per share
-0.17-0.11-0.19-0.21-0.3
Free cash flow per share
-0.31-0.37-0.4-0.6-0.53
Cash per share
3.53.122.732.311.77
Book value per share
5.225.114.944.763.99
Tangible book value per share
3.953.853.693.523.35
Share holders equity per share
5.225.114.944.763.99
Interest debt per share
0.420.421.141.31.28
Market cap
697.22M573.68M387.11M235.69M93.82M
Enterprise value
611.03M498.04M342.6M207.37M79.93M
P/E ratio
-53.62-39.33-17.61-9.5-1.04
Price to sales ratio
74.2456.7434.7320.168.77
POCF ratio
-144.14-186.14-74.43-40.37-11.26
PFCF ratio
-79.74-54.67-34.82-14.06-6.29
P/B Ratio
4.774.012.791.770.84
PTB ratio
4.774.012.791.770.84
EV to sales
65.0649.2630.7417.747.48
Enterprise value over EBITDA
-179.98-121.65-66.94-35.89-3.62
EV to operating cash flow
-126.32-161.6-65.87-35.52-9.59
EV to free cash flow
-69.88-47.46-30.82-12.37-5.36
Earnings yield
0-0.01-0.01-0.03-0.24
Free cash flow yield
-0.01-0.02-0.03-0.07-0.16
Debt to equity
0.160.160.330.370.43
Debt to assets
0.140.140.250.270.3
Net debt to EBITDA
25.3918.488.74.90.63
Current ratio
17.913.077.286.775.68
Interest coverage
0132.42449.46-236.64-327.91
Income quality
1.490.850.950.940.37
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.60.670.650.60.61
Research and developement to revenue
0.150.140.180.170.18
Intangibles to total assets
0.210.210.190.190.11
Capex to operating cash flow
0.812.41.141.870.79
Capex to revenue
-0.42-0.73-0.53-0.93-0.62
Capex to depreciation
-5.22-9.47-7.88-13.79-9.03
Stock based compensation to revenue
0.050.060.070.080.09
Graham number
3.693.874.674.868.47
ROIC
0.10.33-0.19-0.12-0.4
Return on tangible assets
-0.02-0.03-0.04-0.04-0.16
Graham Net
2.912.511.410.870.41
Working capital
104.88M93.46M79.3M68.41M57.74M
Tangible asset value
110.62M107.89M103.52M98.72M94.15M
Net current asset value
88.14M77.9M46.4M31.54M21.79M
Invested capital
0.080.080.230.270.32
Average receivables
5.72M5.21M5.92M6.55M6.15M
Average payables
2.98M2.78M2.64M2.22M2.45M
Average inventory
4.14M4.9M5.91M7.17M9.12M
Days sales outstanding
55.0941.5457.8645.6353.6
Days payables outstanding
58.2739.434719.8552.96
Days of inventory on hand
77.2694.6199.75110.48156.88
Receivables turnover
1.632.171.561.971.68
Payables turnover
1.542.281.914.531.7
Inventory turnover
1.160.950.90.810.57
ROE
-0.02-0.03-0.04-0.05-0.2
Capex per share
-0.14-0.26-0.21-0.39-0.23

TKNO Frequently Asked Questions

What is Alpha Teknova, Inc. stock symbol ?

Alpha Teknova, Inc. is a US stock , located in Hollister of Ca and trading under the symbol TKNO

What is Alpha Teknova, Inc. stock quote today ?

Alpha Teknova, Inc. stock price is $3.26 today.

Is Alpha Teknova, Inc. stock public?

Yes, Alpha Teknova, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap